IL6 and breast carcinoma: Activation of βARs in breast cancer cell lines and osteoblasts also induces the production of IL-6, which has the potential to stimulate the βAR-driven pro-angiogenic pathway by promoting the expression of VEGF [81,158,159,160,161] and the proliferation of breast cancer cells [162,163].